Work

The cancer molecular screening and therapeutics program (MoST): A molecular screening platform with multiple, parallel, signal-seeking therapeutic substudies

Year: 2018

Type: article

Abstract: Background: Innovative approaches are needed to translate molecular opportunities into clinical care. MoST tests a novel paradigm for evaluation of biomarker-driven treatments (tx) for patients (pts) with advanced cancer, with a particular focus on rare or neglected cancers.

Source: Annals of Oncology

DOI: 10.1093/annonc/mdy279.434